Delivery Order SPE2DB20D3505-SPE2DB23FT3W3
- Not listed
- This federal contract award, valued at $4,938.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product. The contract has a completion date of March 15, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,297.53, is a Firm Fixed Price Delivery Order for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award. The company maintains a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, with a ceiling value of $1,374.33. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S. The contract has a ceiling value of $13,594.16 and an ultimate completion date of August 8, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen, a major pharmaceutical distribution and healthcare solutions provider,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,284.32, is a Firm Fixed Price Delivery Order for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S. The contract has a period of performance through February 18, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $15,978.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product, and has an ultimate completion date of October 30, 2024. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a pharmaceutical product. The contract has a ceiling value of $2,410.20 and a completion date of May 30, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed-price basis. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award, with a value of $1,163.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, and falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the parent company Cencora, Inc. (doing business as Amerisourcebergen). This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,563.18 firm fixed price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, with a performance period ending on January 15, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,665.36 firm fixed-price delivery order, awarded on September 4, 2024, is for the supply of scopolamine 1 mg/3 day patches. The contract has an ultimate completion date of September 5, 2024, and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT3W3Delivery Order
This federal contract award, valued at $3,664.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 6, 2022. The award was made on December 5, 2022, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/5/22 |